The IKKβ/NF-κB pathway is required for the development of lung adenocarcinoma in a mouse model, in which a concomitant loss of p53 and expression of oncogenic Kras (G12D) resulted in NF-κB activation [28]. This evidence concerns the gene NFKB1 and lung adenocarcinoma.